TY  - GEN
AU  - Tsai,Donald E
AU  - Maillard,Ivan
AU  - Schuster,Stephen J
AU  - Nasta,Sunita D
AU  - Porter,David L
AU  - Klumpp,Thomas R
AU  - Goldenberg,David M
AU  - Luger,Selina M
AU  - Alavi,Abass
AU  - Sharkey,Robert M
AU  - Hartzell,Kenneth B
AU  - Stadtmauer,Edward A
TI  - Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody
SN  - 1526-9655
PY  - 2003///1118
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, CD20
KW  - Antigens, Differentiation, B-Lymphocyte
KW  - B-Lymphocytes
KW  - Cell Adhesion Molecules
KW  - Disease Progression
KW  - Humans
KW  - Lectins
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Radioimmunotherapy
KW  - methods
KW  - Radiopharmaceuticals
KW  - Sialic Acid Binding Ig-like Lectin 2
KW  - Treatment Outcome
KW  - Yttrium Radioisotopes
KW  - therapeutic use
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3816/clm.2003.n.015
ER  -